Jul 10, 2019
Bayer Trendlines Ag Innovation Fund to Co-invest With Trendlines in New Company
Jun 26, 2019
Bayer to present new data from its hemophilia A portfolio at the International Society of Thrombosis and Haemostasis (ISTH) 2019 annual congress
Jun 19, 2019
Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer
Jun 19, 2019
Bayer Donation of $45,000 Helped Fund Development of Cook Museum of Natural Science
Jun 11, 2019
Bayer Donates $50,000 to the Association of Foreign Correspondents in the United States
Jun 03, 2019
New data on Vitrakvi® (larotrectinib) in TRK fusion cancer patients with brain metastases or primary central nervous system (CNS) tumors
May 29, 2019
Bayer Receives U.S. FDA Breakthrough Therapy Designation for Aliqopa(TM) (copanlisib) for the Treatment of Marginal Zone Lymphoma
May 15, 2019
Bayer presents new analyses for Vitrakvi® (larotrectinib) in adult and pediatric patients with TRK fusion cancer with solid tumors, and new data in primary central nervous system tumors and brain metastases
May 10, 2019
Divya Annamraju, Deputy Director of Strategy for Medical Devices Product Supply at Bayer, Honored as Healthcare Businesswomen's Association Luminary
May 01, 2019
Bayer Launches Test Your Cancer Campaign Empowering Patients to See the Real Picture through Genomic Cancer Testing
Apr 30, 2019
U.S. Environmental Protection Agency is Latest Regulatory Agency to Reaffirm that Glyphosate is Not Carcinogenic
Apr 29, 2019
U.S. FDA accepts New Drug Application and grants Priority Review for darolutamide
Apr 04, 2019
Bayer Only Life Science Company Named as a Most Reputable Company in Biggest-Ever Corporate Reputation Study in U.S.
Apr 02, 2019
Leaps by Bayer and Khloris join forces to develop induced pluripotent stem cells (iPSCs) as breakthrough anti-cancer vaccines
Apr 02, 2019
The Climate Corporation and Lindsay Corporation Partner to Deliver Data-Driven Irrigation Management Insights for Farmers
Mar 27, 2019
Bayer Statement on Jury's Decision in Phase 2 of California Glyphosate Trial
Mar 05, 2019
The Climate Corporation and NAU Country Insurance Company Partner to Enable Seamless Crop Insurance Reporting for U.S. Farmers
Feb 27, 2019
Bayer completes rolling submission of New Drug Application to U.S. Food and Drug Administration for investigational drug darolutamide for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC)
Feb 15, 2019
Bayer to obtain full rights to global development and commercialization of oncology compounds Vitrakvi® (larotrectinib) and BAY 2731954 (LOXO-195)
Feb 14, 2019
Bayer's investigational drug darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer